| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |